nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP2C9—Capecitabine—colon cancer	0.0744	0.322	CbGbCtD
Thioridazine—CYP2C8—Fluorouracil—colon cancer	0.0633	0.274	CbGbCtD
Thioridazine—HTR7—myenteric nerve plexus—colon cancer	0.0535	0.158	CbGeAlD
Thioridazine—CYP1A2—Fluorouracil—colon cancer	0.049	0.212	CbGbCtD
Thioridazine—CYP2C9—Fluorouracil—colon cancer	0.0441	0.191	CbGbCtD
Thioridazine—HTR7—vein—colon cancer	0.0345	0.101	CbGeAlD
Thioridazine—HTR2A—myenteric nerve plexus—colon cancer	0.0333	0.0982	CbGeAlD
Thioridazine—HTR2A—vein—colon cancer	0.0215	0.0633	CbGeAlD
Thioridazine—Miosis—Irinotecan—colon cancer	0.0149	0.035	CcSEcCtD
Thioridazine—Ileus paralytic—Vincristine—colon cancer	0.0148	0.0347	CcSEcCtD
Thioridazine—Parkinsonism—Fluorouracil—colon cancer	0.0131	0.0308	CcSEcCtD
Thioridazine—Trismus—Capecitabine—colon cancer	0.0125	0.0293	CcSEcCtD
Thioridazine—Sudden death—Irinotecan—colon cancer	0.0122	0.0286	CcSEcCtD
Thioridazine—HTR7—endothelium—colon cancer	0.0119	0.0349	CbGeAlD
Thioridazine—Sudden death—Fluorouracil—colon cancer	0.0117	0.0274	CcSEcCtD
Thioridazine—Akathisia—Irinotecan—colon cancer	0.0113	0.0264	CcSEcCtD
Thioridazine—HTR7—blood vessel—colon cancer	0.0109	0.0322	CbGeAlD
Thioridazine—Ileus paralytic—Capecitabine—colon cancer	0.00965	0.0226	CcSEcCtD
Thioridazine—ADRA1B—renal system—colon cancer	0.00848	0.025	CbGeAlD
Thioridazine—Sudden death—Capecitabine—colon cancer	0.00815	0.0191	CcSEcCtD
Thioridazine—HTR2A—endothelium—colon cancer	0.00739	0.0218	CbGeAlD
Thioridazine—HTR2A—blood vessel—colon cancer	0.00682	0.0201	CbGeAlD
Thioridazine—Sudden death—Methotrexate—colon cancer	0.00607	0.0142	CcSEcCtD
Thioridazine—Torsade de pointes—Capecitabine—colon cancer	0.00595	0.014	CcSEcCtD
Thioridazine—Dermatitis contact—Fluorouracil—colon cancer	0.0059	0.0139	CcSEcCtD
Thioridazine—Hepatotoxicity—Capecitabine—colon cancer	0.0054	0.0127	CcSEcCtD
Thioridazine—HTR7—epithelium—colon cancer	0.00532	0.0157	CbGeAlD
Thioridazine—HTR1A—renal system—colon cancer	0.00517	0.0152	CbGeAlD
Thioridazine—ADRA1A—epithelium—colon cancer	0.00513	0.0151	CbGeAlD
Thioridazine—HTR7—smooth muscle tissue—colon cancer	0.00513	0.0151	CbGeAlD
Thioridazine—Eruption—Methotrexate—colon cancer	0.00505	0.0119	CcSEcCtD
Thioridazine—HTR7—renal system—colon cancer	0.00494	0.0145	CbGeAlD
Thioridazine—Photosensitivity—Fluorouracil—colon cancer	0.00494	0.0116	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Irinotecan—colon cancer	0.0048	0.0113	CcSEcCtD
Thioridazine—ADRA1A—renal system—colon cancer	0.00476	0.014	CbGeAlD
Thioridazine—KCNH2—renal system—colon cancer	0.0046	0.0135	CbGeAlD
Thioridazine—Lethargy—Fluorouracil—colon cancer	0.00442	0.0104	CcSEcCtD
Thioridazine—Cardiac arrest—Vincristine—colon cancer	0.00442	0.0104	CcSEcCtD
Thioridazine—Cardiac arrest—Irinotecan—colon cancer	0.0043	0.0101	CcSEcCtD
Thioridazine—CYP2C8—renal system—colon cancer	0.00421	0.0124	CbGeAlD
Thioridazine—Cardiac arrest—Fluorouracil—colon cancer	0.00412	0.00967	CcSEcCtD
Thioridazine—HTR2A—embryo—colon cancer	0.00407	0.012	CbGeAlD
Thioridazine—HTR7—digestive system—colon cancer	0.00405	0.0119	CbGeAlD
Thioridazine—Hepatotoxicity—Methotrexate—colon cancer	0.00402	0.00944	CcSEcCtD
Thioridazine—HRH1—epithelium—colon cancer	0.00397	0.0117	CbGeAlD
Thioridazine—CYP2C19—digestive system—colon cancer	0.00395	0.0116	CbGeAlD
Thioridazine—ADRA1A—lymphoid tissue—colon cancer	0.00395	0.0116	CbGeAlD
Thioridazine—CYP1A2—renal system—colon cancer	0.00394	0.0116	CbGeAlD
Thioridazine—HRH1—smooth muscle tissue—colon cancer	0.00383	0.0113	CbGeAlD
Thioridazine—Pancytopenia—Vincristine—colon cancer	0.00381	0.00895	CcSEcCtD
Thioridazine—Sweating increased—Irinotecan—colon cancer	0.00381	0.00894	CcSEcCtD
Thioridazine—Eosinophilia—Fluorouracil—colon cancer	0.00371	0.00871	CcSEcCtD
Thioridazine—Photosensitivity reaction—Vincristine—colon cancer	0.00367	0.00861	CcSEcCtD
Thioridazine—Pancytopenia—Fluorouracil—colon cancer	0.00356	0.00835	CcSEcCtD
Thioridazine—CYP2E1—renal system—colon cancer	0.00354	0.0104	CbGeAlD
Thioridazine—CYP2C19—vagina—colon cancer	0.00349	0.0103	CbGeAlD
Thioridazine—KCNH2—bone marrow—colon cancer	0.00348	0.0102	CbGeAlD
Thioridazine—Photosensitivity—Capecitabine—colon cancer	0.00345	0.0081	CcSEcCtD
Thioridazine—Photosensitivity reaction—Fluorouracil—colon cancer	0.00342	0.00803	CcSEcCtD
Thioridazine—Jaundice—Irinotecan—colon cancer	0.0034	0.00798	CcSEcCtD
Thioridazine—KCNH2—vagina—colon cancer	0.00333	0.00981	CbGeAlD
Thioridazine—HTR2A—epithelium—colon cancer	0.00332	0.00978	CbGeAlD
Thioridazine—CYP1A2—digestive system—colon cancer	0.00323	0.00951	CbGeAlD
Thioridazine—Dermatitis exfoliative—Capecitabine—colon cancer	0.00321	0.00753	CcSEcCtD
Thioridazine—HTR2A—smooth muscle tissue—colon cancer	0.0032	0.00942	CbGeAlD
Thioridazine—Agranulocytosis—Fluorouracil—colon cancer	0.00312	0.00732	CcSEcCtD
Thioridazine—Lethargy—Capecitabine—colon cancer	0.00309	0.00726	CcSEcCtD
Thioridazine—HTR2A—renal system—colon cancer	0.00308	0.00907	CbGeAlD
Thioridazine—CYP2C9—digestive system—colon cancer	0.00307	0.00903	CbGeAlD
Thioridazine—CYP2C8—vagina—colon cancer	0.00305	0.00898	CbGeAlD
Thioridazine—HRH1—digestive system—colon cancer	0.00302	0.0089	CbGeAlD
Thioridazine—HTR7—liver—colon cancer	0.00302	0.00889	CbGeAlD
Thioridazine—CYP2C19—liver—colon cancer	0.00295	0.00868	CbGeAlD
Thioridazine—CYP2E1—lymphoid tissue—colon cancer	0.00294	0.00866	CbGeAlD
Thioridazine—Aplastic anaemia—Methotrexate—colon cancer	0.00292	0.00685	CcSEcCtD
Thioridazine—ADRA1A—liver—colon cancer	0.00291	0.00857	CbGeAlD
Thioridazine—CYP2E1—digestive system—colon cancer	0.00291	0.00856	CbGeAlD
Thioridazine—Cardiac arrest—Capecitabine—colon cancer	0.00288	0.00676	CcSEcCtD
Thioridazine—Mental disorder—Vincristine—colon cancer	0.00282	0.00661	CcSEcCtD
Thioridazine—CYP2D6—renal system—colon cancer	0.0028	0.00826	CbGeAlD
Thioridazine—Arrhythmia—Irinotecan—colon cancer	0.0028	0.00656	CcSEcCtD
Thioridazine—Gynaecomastia—Methotrexate—colon cancer	0.00278	0.00652	CcSEcCtD
Thioridazine—Arrhythmia—Fluorouracil—colon cancer	0.00268	0.00629	CcSEcCtD
Thioridazine—HRH1—vagina—colon cancer	0.00267	0.00786	CbGeAlD
Thioridazine—ADRA2A—vagina—colon cancer	0.00262	0.00772	CbGeAlD
Thioridazine—Asthma—Capecitabine—colon cancer	0.00262	0.00614	CcSEcCtD
Thioridazine—Erythema—Fluorouracil—colon cancer	0.00261	0.00613	CcSEcCtD
Thioridazine—Anaemia—Vincristine—colon cancer	0.00259	0.00607	CcSEcCtD
Thioridazine—Agitation—Vincristine—colon cancer	0.00257	0.00604	CcSEcCtD
Thioridazine—CYP2C8—liver—colon cancer	0.00257	0.00757	CbGeAlD
Thioridazine—Photosensitivity—Methotrexate—colon cancer	0.00257	0.00603	CcSEcCtD
Thioridazine—Sweating increased—Capecitabine—colon cancer	0.00255	0.00599	CcSEcCtD
Thioridazine—HTR2A—digestive system—colon cancer	0.00252	0.00744	CbGeAlD
Thioridazine—Anaemia—Irinotecan—colon cancer	0.00252	0.00591	CcSEcCtD
Thioridazine—Leukopenia—Vincristine—colon cancer	0.00251	0.00588	CcSEcCtD
Thioridazine—Pancytopenia—Capecitabine—colon cancer	0.00249	0.00584	CcSEcCtD
Thioridazine—Vision blurred—Fluorouracil—colon cancer	0.00246	0.00577	CcSEcCtD
Thioridazine—Leukopenia—Irinotecan—colon cancer	0.00244	0.00573	CcSEcCtD
Thioridazine—Anaemia—Fluorouracil—colon cancer	0.00241	0.00566	CcSEcCtD
Thioridazine—CYP1A2—liver—colon cancer	0.00241	0.00709	CbGeAlD
Thioridazine—Dermatitis exfoliative—Methotrexate—colon cancer	0.00239	0.00561	CcSEcCtD
Thioridazine—Photosensitivity reaction—Capecitabine—colon cancer	0.00239	0.00561	CcSEcCtD
Thioridazine—Weight increased—Capecitabine—colon cancer	0.00238	0.00559	CcSEcCtD
Thioridazine—Leukopenia—Fluorouracil—colon cancer	0.00234	0.00548	CcSEcCtD
Thioridazine—Lethargy—Methotrexate—colon cancer	0.0023	0.0054	CcSEcCtD
Thioridazine—CYP2D6—digestive system—colon cancer	0.0023	0.00678	CbGeAlD
Thioridazine—Oedema—Vincristine—colon cancer	0.00228	0.00536	CcSEcCtD
Thioridazine—CYP2C9—liver—colon cancer	0.00228	0.00673	CbGeAlD
Thioridazine—Jaundice—Capecitabine—colon cancer	0.00228	0.00534	CcSEcCtD
Thioridazine—Confusional state—Irinotecan—colon cancer	0.00224	0.00526	CcSEcCtD
Thioridazine—Thrombocytopenia—Vincristine—colon cancer	0.00224	0.00525	CcSEcCtD
Thioridazine—HTR2A—vagina—colon cancer	0.00223	0.00657	CbGeAlD
Thioridazine—Oedema—Irinotecan—colon cancer	0.00222	0.00522	CcSEcCtD
Thioridazine—Hyperhidrosis—Vincristine—colon cancer	0.00221	0.00518	CcSEcCtD
Thioridazine—Agranulocytosis—Capecitabine—colon cancer	0.00218	0.00511	CcSEcCtD
Thioridazine—Thrombocytopenia—Irinotecan—colon cancer	0.00218	0.00511	CcSEcCtD
Thioridazine—Anorexia—Vincristine—colon cancer	0.00218	0.00511	CcSEcCtD
Thioridazine—CYP2E1—liver—colon cancer	0.00216	0.00637	CbGeAlD
Thioridazine—KCNH2—lymph node—colon cancer	0.00215	0.00635	CbGeAlD
Thioridazine—Hyperhidrosis—Irinotecan—colon cancer	0.00215	0.00505	CcSEcCtD
Thioridazine—Confusional state—Fluorouracil—colon cancer	0.00215	0.00504	CcSEcCtD
Thioridazine—Hypotension—Vincristine—colon cancer	0.00213	0.00501	CcSEcCtD
Thioridazine—Oedema—Fluorouracil—colon cancer	0.00213	0.005	CcSEcCtD
Thioridazine—Anorexia—Irinotecan—colon cancer	0.00212	0.00498	CcSEcCtD
Thioridazine—Thrombocytopenia—Fluorouracil—colon cancer	0.00209	0.0049	CcSEcCtD
Thioridazine—Tachycardia—Fluorouracil—colon cancer	0.00208	0.00488	CcSEcCtD
Thioridazine—Hypotension—Irinotecan—colon cancer	0.00208	0.00488	CcSEcCtD
Thioridazine—Oedema peripheral—Capecitabine—colon cancer	0.00206	0.00485	CcSEcCtD
Thioridazine—Anorexia—Fluorouracil—colon cancer	0.00203	0.00477	CcSEcCtD
Thioridazine—Hypotension—Fluorouracil—colon cancer	0.00199	0.00467	CcSEcCtD
Thioridazine—Decreased appetite—Vincristine—colon cancer	0.00199	0.00466	CcSEcCtD
Thioridazine—Somnolence—Irinotecan—colon cancer	0.00198	0.00464	CcSEcCtD
Thioridazine—Constipation—Vincristine—colon cancer	0.00195	0.00458	CcSEcCtD
Thioridazine—Asthma—Methotrexate—colon cancer	0.00195	0.00457	CcSEcCtD
Thioridazine—Decreased appetite—Irinotecan—colon cancer	0.00193	0.00454	CcSEcCtD
Thioridazine—Eosinophilia—Methotrexate—colon cancer	0.00193	0.00453	CcSEcCtD
Thioridazine—Constipation—Irinotecan—colon cancer	0.0019	0.00446	CcSEcCtD
Thioridazine—Somnolence—Fluorouracil—colon cancer	0.00189	0.00445	CcSEcCtD
Thioridazine—HTR2A—liver—colon cancer	0.00188	0.00554	CbGeAlD
Thioridazine—Arrhythmia—Capecitabine—colon cancer	0.00187	0.00439	CcSEcCtD
Thioridazine—Decreased appetite—Fluorouracil—colon cancer	0.00185	0.00435	CcSEcCtD
Thioridazine—Pancytopenia—Methotrexate—colon cancer	0.00185	0.00434	CcSEcCtD
Thioridazine—Mental disorder—Capecitabine—colon cancer	0.00184	0.00431	CcSEcCtD
Thioridazine—Feeling abnormal—Irinotecan—colon cancer	0.00183	0.0043	CcSEcCtD
Thioridazine—Erythema—Capecitabine—colon cancer	0.00182	0.00428	CcSEcCtD
Thioridazine—Body temperature increased—Vincristine—colon cancer	0.00181	0.00424	CcSEcCtD
Thioridazine—Photosensitivity reaction—Methotrexate—colon cancer	0.00178	0.00418	CcSEcCtD
Thioridazine—Body temperature increased—Irinotecan—colon cancer	0.00176	0.00413	CcSEcCtD
Thioridazine—Feeling abnormal—Fluorouracil—colon cancer	0.00176	0.00412	CcSEcCtD
Thioridazine—Drowsiness—Methotrexate—colon cancer	0.00174	0.00408	CcSEcCtD
Thioridazine—HRH1—lymph node—colon cancer	0.00173	0.00509	CbGeAlD
Thioridazine—Vision blurred—Capecitabine—colon cancer	0.00172	0.00404	CcSEcCtD
Thioridazine—CYP2D6—liver—colon cancer	0.00171	0.00505	CbGeAlD
Thioridazine—Tremor—Capecitabine—colon cancer	0.00171	0.00401	CcSEcCtD
Thioridazine—ADRA2A—lymph node—colon cancer	0.0017	0.005	CbGeAlD
Thioridazine—Anaemia—Capecitabine—colon cancer	0.00169	0.00396	CcSEcCtD
Thioridazine—Body temperature increased—Fluorouracil—colon cancer	0.00168	0.00395	CcSEcCtD
Thioridazine—Hypersensitivity—Vincristine—colon cancer	0.00168	0.00395	CcSEcCtD
Thioridazine—Hypersensitivity—Irinotecan—colon cancer	0.00164	0.00385	CcSEcCtD
Thioridazine—Leukopenia—Capecitabine—colon cancer	0.00163	0.00383	CcSEcCtD
Thioridazine—Agranulocytosis—Methotrexate—colon cancer	0.00162	0.00381	CcSEcCtD
Thioridazine—Hypersensitivity—Fluorouracil—colon cancer	0.00157	0.00368	CcSEcCtD
Thioridazine—Diarrhoea—Vincristine—colon cancer	0.00156	0.00367	CcSEcCtD
Thioridazine—Diarrhoea—Irinotecan—colon cancer	0.00152	0.00357	CcSEcCtD
Thioridazine—Confusional state—Capecitabine—colon cancer	0.0015	0.00352	CcSEcCtD
Thioridazine—Oedema—Capecitabine—colon cancer	0.00149	0.00349	CcSEcCtD
Thioridazine—Diarrhoea—Fluorouracil—colon cancer	0.00146	0.00342	CcSEcCtD
Thioridazine—Thrombocytopenia—Capecitabine—colon cancer	0.00146	0.00342	CcSEcCtD
Thioridazine—Tachycardia—Capecitabine—colon cancer	0.00145	0.00341	CcSEcCtD
Thioridazine—Vomiting—Vincristine—colon cancer	0.00145	0.00341	CcSEcCtD
Thioridazine—Rash—Vincristine—colon cancer	0.00144	0.00338	CcSEcCtD
Thioridazine—Hyperhidrosis—Capecitabine—colon cancer	0.00144	0.00338	CcSEcCtD
Thioridazine—Dermatitis—Vincristine—colon cancer	0.00144	0.00338	CcSEcCtD
Thioridazine—Headache—Vincristine—colon cancer	0.00143	0.00336	CcSEcCtD
Thioridazine—Anorexia—Capecitabine—colon cancer	0.00142	0.00333	CcSEcCtD
Thioridazine—Vomiting—Irinotecan—colon cancer	0.00141	0.00332	CcSEcCtD
Thioridazine—Rash—Irinotecan—colon cancer	0.0014	0.00329	CcSEcCtD
Thioridazine—Dermatitis—Irinotecan—colon cancer	0.0014	0.00329	CcSEcCtD
Thioridazine—Headache—Irinotecan—colon cancer	0.00139	0.00327	CcSEcCtD
Thioridazine—Hypotension—Capecitabine—colon cancer	0.00139	0.00327	CcSEcCtD
Thioridazine—Mental disorder—Methotrexate—colon cancer	0.00137	0.00321	CcSEcCtD
Thioridazine—Erythema—Methotrexate—colon cancer	0.00136	0.00319	CcSEcCtD
Thioridazine—Nausea—Vincristine—colon cancer	0.00136	0.00318	CcSEcCtD
Thioridazine—Vomiting—Fluorouracil—colon cancer	0.00135	0.00318	CcSEcCtD
Thioridazine—Rash—Fluorouracil—colon cancer	0.00134	0.00315	CcSEcCtD
Thioridazine—Dermatitis—Fluorouracil—colon cancer	0.00134	0.00315	CcSEcCtD
Thioridazine—Headache—Fluorouracil—colon cancer	0.00133	0.00313	CcSEcCtD
Thioridazine—Nausea—Irinotecan—colon cancer	0.00132	0.0031	CcSEcCtD
Thioridazine—Decreased appetite—Capecitabine—colon cancer	0.00129	0.00304	CcSEcCtD
Thioridazine—Vision blurred—Methotrexate—colon cancer	0.00128	0.003	CcSEcCtD
Thioridazine—Constipation—Capecitabine—colon cancer	0.00127	0.00299	CcSEcCtD
Thioridazine—Nausea—Fluorouracil—colon cancer	0.00127	0.00297	CcSEcCtD
Thioridazine—Anaemia—Methotrexate—colon cancer	0.00126	0.00295	CcSEcCtD
Thioridazine—Feeling abnormal—Capecitabine—colon cancer	0.00123	0.00288	CcSEcCtD
Thioridazine—Leukopenia—Methotrexate—colon cancer	0.00122	0.00285	CcSEcCtD
Thioridazine—Body temperature increased—Capecitabine—colon cancer	0.00118	0.00276	CcSEcCtD
Thioridazine—Confusional state—Methotrexate—colon cancer	0.00112	0.00262	CcSEcCtD
Thioridazine—Hypersensitivity—Capecitabine—colon cancer	0.0011	0.00257	CcSEcCtD
Thioridazine—Thrombocytopenia—Methotrexate—colon cancer	0.00109	0.00255	CcSEcCtD
Thioridazine—Hyperhidrosis—Methotrexate—colon cancer	0.00107	0.00251	CcSEcCtD
Thioridazine—Anorexia—Methotrexate—colon cancer	0.00106	0.00248	CcSEcCtD
Thioridazine—Hypotension—Methotrexate—colon cancer	0.00104	0.00243	CcSEcCtD
Thioridazine—Diarrhoea—Capecitabine—colon cancer	0.00102	0.00239	CcSEcCtD
Thioridazine—Somnolence—Methotrexate—colon cancer	0.000985	0.00231	CcSEcCtD
Thioridazine—Decreased appetite—Methotrexate—colon cancer	0.000963	0.00226	CcSEcCtD
Thioridazine—Vomiting—Capecitabine—colon cancer	0.000947	0.00222	CcSEcCtD
Thioridazine—Rash—Capecitabine—colon cancer	0.000939	0.0022	CcSEcCtD
Thioridazine—Dermatitis—Capecitabine—colon cancer	0.000938	0.0022	CcSEcCtD
Thioridazine—Headache—Capecitabine—colon cancer	0.000933	0.00219	CcSEcCtD
Thioridazine—Feeling abnormal—Methotrexate—colon cancer	0.000913	0.00214	CcSEcCtD
Thioridazine—Nausea—Capecitabine—colon cancer	0.000884	0.00208	CcSEcCtD
Thioridazine—Body temperature increased—Methotrexate—colon cancer	0.000876	0.00206	CcSEcCtD
Thioridazine—Eletriptan—ABCB1—colon cancer	0.000862	0.239	CrCbGaD
Thioridazine—Hypersensitivity—Methotrexate—colon cancer	0.000817	0.00192	CcSEcCtD
Thioridazine—Diarrhoea—Methotrexate—colon cancer	0.000758	0.00178	CcSEcCtD
Thioridazine—Vomiting—Methotrexate—colon cancer	0.000705	0.00165	CcSEcCtD
Thioridazine—Rash—Methotrexate—colon cancer	0.000699	0.00164	CcSEcCtD
Thioridazine—Dermatitis—Methotrexate—colon cancer	0.000698	0.00164	CcSEcCtD
Thioridazine—Headache—Methotrexate—colon cancer	0.000694	0.00163	CcSEcCtD
Thioridazine—Nausea—Methotrexate—colon cancer	0.000658	0.00155	CcSEcCtD
Thioridazine—Triflupromazine—ABCB1—colon cancer	0.000653	0.181	CrCbGaD
Thioridazine—Fluphenazine—ABCB1—colon cancer	0.000502	0.14	CrCbGaD
Thioridazine—Clomipramine—ABCB1—colon cancer	0.00046	0.128	CrCbGaD
Thioridazine—Promethazine—ABCB1—colon cancer	0.000407	0.113	CrCbGaD
Thioridazine—Trifluoperazine—ABCB1—colon cancer	0.000402	0.112	CrCbGaD
Thioridazine—Chlorpromazine—ABCB1—colon cancer	0.000315	0.0875	CrCbGaD
